Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2023-03-17 00:00:00 ET · period of report 2023-03-15 · accession 0001209191-23-019944 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-17 | 2023-03-15 | TMCI | Owens Daniel E. | CHRO | M - OptEx | $7.03 | +6,250 | 37.2K | +20% | +$43.9K |
| D | 2023-03-17 | 2023-03-15 | TMCI | Owens Daniel E. | CHRO | S - Sale+OE | $22.87 | -6,250 | 30.9K | -17% | -$142.9K |
| D | 2023-03-17 | 2023-03-15 | TMCI | Owens Daniel E. | CHRO | M - OptEx | $0.00 | -6,250 | 176.4K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-15 | M | A | 6,250 | $7.03 | 37,164 | D | — | — | (F2) Includes 25,650 RSUs. |
| 2 | Common | Common Stock | 2023-03-15 | S | D | 6,250 | $22.87 | 30,914 | D | — | — | (F3) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.6600 to $23.3900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F2) Includes 25,650 RSUs. |
| 3 | Derivative | Stock Option Right to Buy | 2023-03-15 | M | D | 6,250 | $0.00 | 176,375 | D | $7.03 · — to 2031-02-02 | 6,250 Stock Option Right to Buy | (F4) The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date. |